Rick Simpson Oil (RSO) in Van Buren County, Iowa: The Complete Guide by OilWell Cannabis

Understanding Rick Simpson Oil — From Nova Scotia to Iowa’s Heartland

Who is Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor, scientist, or medical professional — he was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him. Here in Van Buren County, we know what it’s like when the medical system fails you. When the closest major hospital is over an hour away in Ottumwa or Burlington, when specialist appointments require a full day of travel to Iowa City or Des Moines, when you’re told “there’s nothing more we can do” by a doctor who barely knows your name — that’s the frustration that drives people to seek alternatives.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. The medications prescribed either failed to help or made his condition worse. Sound familiar, Van Buren County? How many of our neighbors have been through the same cycle — work injury, chronic pain, pills that don’t work or create new problems, doctors who dismiss cannabis as an option? Simpson found that cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe it, the request was refused .

Simpson’s interest in concentrated cannabis oil deepened after learning about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, where THC was reported to slow or shrink tumors in mice. That study — originally intended to demonstrate harm — became a foundational reference point in Simpson’s advocacy, even though its findings were never replicated in controlled human cancer trials .

The pivotal moment came in 2003. Three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification has been published, and no biopsy confirmation or clinical follow-up exists in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil and the foundation of everything that followed .

Important context: Simpson’s account is presented here as personal testimony. The absence of clinical documentation means these events cannot be evaluated as medical evidence. They are, however, historically significant as the catalyst for a global movement. In Van Buren County, where personal experience and word-of-mouth carry weight in health decisions, we understand why stories like this resonate — but we also believe in separating powerful anecdotes from proven medicine.

The Crusade — Spreading the Oil Across Borders and State Lines

After his 2003 experience, Simpson committed himself to producing and distributing concentrated cannabis oil, giving it away for free to cancer patients and others in his community. He never charged. By his account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more . Here in Van Buren County, we know people facing these exact battles. In a county of just 7,000 souls, every cancer diagnosis, every veteran with PTSD, every farmer with chronic back pain from decades of labor — these aren’t statistics, they’re our neighbors.

Simpson’s story reached global audiences through the 2005 documentary Run From The Cure, which became foundational in cannabis communities worldwide. But his advocacy brought him into direct conflict with Canadian law. The RCMP raided his property in 2005 and 2009. He was charged with cultivation, possession, and trafficking. Eventually, he left Canada for Europe, living in Croatia and the Netherlands, continuing his advocacy from abroad .

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his platform . Throughout his career, he maintained an uncompromising position: cannabis oil could cure cancer, and pharmaceutical companies, government agencies, and medical institutions were actively suppressing this knowledge to protect financial interests .

Important context: Simpson’s conspiratorial framing reflects a worldview shared by many in the early cannabis movement and is relevant to understanding RSO’s cultural significance. Here in Van Buren County, where pharmaceutical distrust runs deep — especially after the opioid crisis hit rural Iowa so hard — we understand that sentiment, even as we commit to evidence-based education.

The Traditional RSO Protocol — Simpson’s 90-Day Regimen

Simpson’s core recommendation was a structured oral protocol delivering 60 grams of concentrated cannabis oil over approximately 90 days. Here’s the breakdown as he described it :

Goal: Consume 60 grams over roughly 90 days. Simpson considered this the minimum for serious cancer treatment.

Titration schedule:

• Week 1: Half a grain of rice-sized dose — about 10-15mg — three times daily (total 30-45mg/day)
• Weeks 2-5: Double the dose every four days, aiming for 1 gram (1,000mg) per day by week five
• Weeks 5-12: Maintain 1 gram per day divided into three doses until all 60 grams are consumed

Administration methods:

• Oral: Primary method — sublingual or swallowed
• Topical: For skin cancers, applied directly with bandages changed every 3-4 days
• Inhalation: Not recommended as primary treatment, though acknowledged for immediate symptom relief

Tolerance and psychoactive effects: Simpson claimed patients develop tolerance within 3-4 weeks, recommended nighttime dosing initially, and warned against driving during titration.

Post-protocol maintenance: After completing 60 grams, Simpson recommended 1-2 grams per month indefinitely.

Important Context for Evaluating This Protocol

This protocol was designed by one person based on personal experience, not clinical trials. Several critical points apply:

• No controlled trial validation. No published randomized controlled trials, cohort studies, or well-documented case series evaluate this specific protocol for any condition.
• Assumes crude, unstandardized material. The 60-gram quantity assumes single-strain, THC-dominant extract with no standardized potency — actual THC content varied widely.
• Very high THC exposure. At peak dosing, patients consumed roughly 1 gram of high-THC oil daily. Assuming 60-90% THC, that’s 600-900mg of delta-9 THC per day — far exceeding anything studied in controlled settings. For context, FDA-approved dronabinol is typically dosed at 2.5-20mg per day.
• Real risks at these doses. Consuming 600-900mg of THC daily carries serious risks: severe intoxication, impairment, anxiety, panic, tachycardia, hypotension, and cannabis use disorder [1][13][14][15].
• Oncology context. Patients with active cancer are medically complex. Using unregulated, unstandardized cannabis oil as primary treatment — potentially in place of proven therapies — introduces harm beyond the oil itself.

What Traditional RSO Was as a Product

Source material: High-THC indica strains, no standardization. Whatever the grower had available.

Extraction solvent: Naphtha (petroleum-based) or 99% isopropyl alcohol — neither food-grade. Naphtha may contain benzene, toluene, and other carcinogens. Incomplete purging leaves harmful residues.

Extraction process: Bucket, solvent, agitation, filtering, rice cooker evaporation, syringes. Simple but risky — the rice cooker heat destroys terpenes and creates fire hazards, especially concerning in rural Iowa where emergency response times can be long.

Appearance: Nearly black, thick, tar-like oil with strong cannabis odor and possible solvent-residual smell.

Cannabinoid profile: THC-dominant (60-90% estimated), fully decarboxylated, minor cannabinoids at natural ratios — uncontrolled, unmeasured, never lab-verified.

Terpene content: Minimal to none. The solvent and heat process strips them completely.

Standardization and testing: None. Every batch different. No COA, no quantification, no safety screening.

Residual solvent risk: This is one of the most significant safety concerns. Traditional RSO production using naphtha or isopropyl alcohol creates real health risks that modern methods have solved.

Simpson’s Claims vs. The Evidence Record

Simpson claimed RSO could cure cancer and many other diseases. Let’s evaluate those claims against actual evidence:

What Simpson was not: He had no formal training in medicine, oncology, pharmacology, or clinical research. He never designed, conducted, or published a trial. His evidence base consisted of personal experience and testimonials with no controls, no independent verification, no imaging confirmation, no long-term follow-up, and no blinding.

What the preclinical literature shows: In vitro studies demonstrate that THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines . Animal models show some tumor-growth inhibition . These findings generate legitimate scientific interest.

What the preclinical literature does NOT show: These findings have not translated into proven human cancer cures. The gap between in vitro/animal results and human outcomes is vast. No human clinical trial has demonstrated that RSO or any cannabis oil cures cancer .

Institutional positions:

• NCI: Acknowledges cannabinoids have been studied for potential anticancer effects in lab and animal models but does not endorse cannabis or cannabis oil as cancer treatment .
• FDA: Has not approved any cannabis plant product for cancer treatment. Only purified CBD (Epidiolex) and synthetic THC analogues (dronabinol, nabilone) have specific approvals for other indications [1].
• Health Canada: Has never approved RSO or cannabis oil as a cancer cure.
• NCCIH: Identifies strongest evidence for rare epilepsies, chemo nausea, and HIV/AIDS appetite — not cancer cure [1].

What Simpson got right: He drew attention to cannabinoids as serious biomedical research when the world ignored it. His advocacy helped create conditions for legal cannabis industry and research infrastructure. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated: The leap from preclinical signals to cancer cure was not supported then and is not supported now. Encouraging patients — especially cancer patients — to rely on RSO as primary treatment in place of proven oncologic therapies carries genuine harm potential. Delayed or foregone treatment for treatable cancers is a documented concern in alternative medicine.

The Legacy of Rick Simpson and Modern RSO Evolution

The term RSO is now used broadly and loosely across the legal cannabis industry. Many products labeled RSO bear little resemblance to what Simpson originally made. Simpson himself has been critical of commercial products using the RSO name while departing from his method and philosophy .

Simpson’s model was explicitly anti-commercial — he gave oil away free and urged people to make their own. The modern cannabis industry has commercialized, standardized, and regulated what Simpson distributed freely. Whether that’s improvement (quality control, lab testing) or betrayal (profit extraction, gatekeeping) depends on perspective.

What is not in dispute is that modern RSO has evolved substantially. The following table shows key differences:

Dimension	Traditional RSO	OilWell Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled, 60-90% THC	7 defined cannabinoids at specific ratios
Terpene content	Destroyed by heat	Live terpenes at 5% with defined 7-terpene profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets (553mg/mL)
Lab testing	Not performed	Full panel testing for potency, terpenes, pesticides, heavy metals, residual solvents, microbial contaminants
Residual solvents	Significant risk with naphtha	Controlled and tested — solvent-free production
Dosing precision	Approximate, syringe-based	Measured per mL with known cannabinoid content
Product formats	Single thick oil only	Sublingual oil and vape cartridge with format-specific formulas
THCa preservation	No — fully decarboxylated by heat	Yes — THCa included as separate ingredient at 1,500mg
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

Why OilWell’s Formulas Diverge From Traditional RSO

Our formulations are not traditional RSO. They are informed by the RSO tradition but depart deliberately:

Multi-cannabinoid approach. Traditional RSO relied on whatever single strain was available. Our formulas intentionally include seven cannabinoids — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — because the entourage-effect literature suggests potential benefit from cannabinoid diversity [20][29].

Terpene preservation and addition. Traditional RSO had essentially no terpene content. We include live terpenes at 5% with a defined seven-terpene profile — limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene — because terpene bioactivity is plausible at the preclinical level, even if human clinical confirmation remains limited [20][21][23][24][25][26][27][28][29].

THCa as a separate ingredient. Traditional RSO fully decarboxylated everything. Our sublingual formula includes THCa at 1,500mg as a distinct ingredient, preserving the acidic precursor because the THCa literature suggests potentially relevant non-psychoactive bioactivity [12].

Reduced delta-9 THC dominance. Traditional RSO was overwhelmingly delta-9 THC (60-90%). Our sublingual formula uses delta-9 THC at only 90mg while distributing cannabinoid content across CBD (4,500mg), CBG (3,000mg), delta-8 THC (6,000mg), CBN (750mg), and CBC (750mg).

Product format innovation. Simpson envisioned only oral oil from a syringe. We offer both a 30mL sublingual oil and a 1-gram vape cartridge, acknowledging that different delivery routes have different pharmacokinetic profiles [14].

Solvent Safety and Extraction Evolution

Traditional RSO used naphtha or isopropyl alcohol — neither food-grade. Naphtha contains petroleum hydrocarbons including benzene, toluene, and xylene — compounds with established toxicity. Incomplete purging leaves harmful residues.

Modern cannabis extraction uses food-grade ethanol or supercritical CO₂, allowing complete solvent removal with validated analytical testing (headspace gas chromatography). This is one of the most straightforward improvements the modern regulated industry has made.

Our RSO is not an extraction product. It’s a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled environment — no naphtha, no isopropyl alcohol, no butane, no extraction solvents in the finished product.

We use organic MCT oil (medium-chain triglycerides) as the carrier base — food-grade, facilitating sublingual absorption, with neutral taste. This is a significant improvement over traditional RSO’s tar-like consistency and solvent-residual odor.

Third-party lab testing covers potency, terpenes, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on request and through our website.

The Decarboxylation Question

Traditional RSO was fully decarboxylated. Rice cooker heat (60-80°C) converted all THCa to delta-9 THC, losing acidic cannabinoids as distinct compounds.

Our sublingual formula deliberately preserves THCa at 1,500mg. This creates three usage options:

Option 1 — Raw, no heat: All 1,500mg stays as THCa — completely non-psychoactive. The THCa evidence profile describes potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This is compatible with work, driving, and daytime use with zero impairment — crucial for Van Buren County residents who operate farm equipment, drive long distances for work, or need functional relief while parenting.

Option 2 — Fully activated, home decarboxylation: Heating oil at 260°F (125°C) for 45-60 minutes converts 1,500mg THCa to ~1,315mg delta-9 THC. Combined with the existing 90mg delta-9 THC, this yields ~1,405mg total delta-9 THC. Combined with 6,000mg delta-8 THC, the activated product achieves psychoactive potency comparable to traditional illegal RSO — 100% legally, because decarboxylation occurs at the customer’s discretion after purchase. Customers may transfer a controlled portion to an oven-safe glass container, decarboxylating only what they intend to use while preserving the remainder raw.

Option 3 — Vape, auto-decarboxylation: Our vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids — the fastest-onset RSO delivery method available.

The conversion chemistry: THCa molecular weight is 358.47 g/mol. The ratio is ~1mg THCa = 0.877mg delta-9 THC after decarboxylation, reflecting CO₂ molecule loss.

This design puts potency control entirely in the customer’s hands — aligning with Rick Simpson’s principle that patients should control their medicine, but implementing it through actual product chemistry.

The OilWell Story — From McAllen to Montrose, and Why It Matters for Van Buren County

The Origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. But the story doesn’t start in Houston — it starts in McAllen, Texas, right across the river from Reynosa, Tamaulipas, Mexico. The McAllen-Reynosa area, known as the Borderplex, is one of the most economically challenged and dangerous regions along the U.S.-Mexico border.

Here in Van Buren County, we know what it means to grow up in a place with limited opportunities. When the nearest Walmart is 45 minutes away in Fairfield, when good-paying jobs are scarce, when the economy runs on agriculture and not much else — we understand the desperation that drives people to take risks. Colin’s childhood involved transporting items across the border for various groups. His best friends have been killed or are in prison because of those associated dangers. He faced every form of violence imaginable, both in the streets and across the border. By sixteen, he had to leave home for good.

Despite the dangers, Colin didn’t fall into selling harder substances. He focused on cannabis, seeing it as a safer and more beneficial alternative. He grew up in the traditional cannabis world long before legalization, learning the plant intimately while operating in the shadows. Over time, he transitioned from those early, risky ventures to creating a legal, legitimate business in an industry he believes in.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine, one of the most prestigious medical institutions in the Texas Medical Center. That combination — deep cannabis plant knowledge plus medical-grade technical precision — would eventually define OilWell’s approach.

Bentley’s Story — The Foundation of Everything

The company’s origin story begins with a dog named Bentley. Bentley was more than a pet — he was family. When Bentley fell seriously ill, veterinarians delivered the verdict no pet owner wants to hear: euthanasia was the only humane option. Bentley was paralyzed in his back legs. They said pain medications would destroy his internal organs, causing more suffering. The choice was painful prolonged decline or immediate mercy killing.

But giving up on Bentley wasn’t an option. In a desperate search for alternatives, Colin stumbled upon CBD through a question that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?” asked a rescue worker named Jessica.

Colin had cannabis experience — but it was recreational. Getting high. He had never explored therapeutic applications. Jessica’s question exposed a blind spot that would become a mission.

Determined to save Bentley, Colin learned to create CBD golden paste — a specialized cannabinoid formula for pets. It was not a cure, but it was a lifeline. And that hope delivered something veterinary medicine said was impossible: Bentley got up. He walked over to Colin and brought him his ball to play. From paralyzed and facing euthanasia to fetching his ball. This was not placebo effect — dogs do not respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized cannabis formulas for every age-related condition Bentley faced:

• Neurodegeneration led him to understand CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia led him to CBC’s role in neurogenesis
• Glaucoma led him to THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis led him to develop multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Here in Van Buren County, where we cherish our farm dogs and hunting companions as family members, where veterinary care is expensive and often requires traveling to Ottumwa or Fairfield, Bentley’s story resonates deeply. We’ve seen our own animals suffer, and we’ve searched for alternatives when conventional care failed. The fact that a Texas man’s mission to save his dog created the foundation for a product that can now help people in Keosauqua, Birmingham, Milton, and Bonaparte — that’s the kind of authentic origin story that can’t be manufactured.

From Personal Pain to Universal Mission

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction — a story that will sound familiar to many Van Buren County veterans and trauma survivors. When he decided to break free from Xanax, he did it cold turkey — notoriously difficult and dangerous — using the cannabinoid knowledge he developed keeping Bentley alive. The Peace Gummies formula that became an OilWell product was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, OilWell also offers the Peace Gummies formula in a vape form, which Colin personally uses to manage his insomnia and severe PTSD on an ongoing basis.

This is not theoretical knowledge. Colin lived what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills do not.

Over time, the therapeutic benefits of cannabis that Colin first discovered through his efforts to save Bentley became the core of his work. He has developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been on making cannabis accessible and effective for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 Houston — Seven Features Spanning Four Years

Between September 2019 and April 2023, ABC13 Houston (KTRK) — the ABC affiliate serving America’s fourth-largest city — featured Colin Valencia and OilWell Cannabis in seven distinct news segments spanning business, law, medicine, community health, and politics. Five different ABC13 reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers. No other Houston cannabis operator appears with that frequency or breadth.

This matters for Van Buren County because mainstream media validation from a major-market ABC affiliate establishes credibility that transcends geography. When we reach out to Van Buren County from Houston, we’re not an anonymous online brand — we’re a company with a documented track record of being the go-to cannabis authority for a major news organization.

September 15, 2019 — CBD Business Boom: This is where Colin’s foundational quote originated: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” That principle from 2019 drives everything we do in Van Buren County today.

May 24, 2021 — Delta-8 THC “Legal Weed”: Steve Campion’s investigative feature included Colin’s iconic exchange: “Maybe you want to get high.” That radical honesty on mainstream television — balanced with medical expert caution and regulatory advocacy context — demonstrated our commitment to telling the truth, even when it’s uncomfortable.

August 20, 2021 — COVID Vaccine Giveaway: OilWell gave away 1,000 special edition caviar pre-rolls (approximately $35,000 in product) to encourage COVID-19 vaccination. We coordinated with the city of Houston to help more people get vaccinated, with no political agenda. When Van Buren County faced its own pandemic challenges, we were stepping up in Houston — because community health matters everywhere.

October 19, 2021 — Delta-8 Ban Impact: When Texas classified Delta-8 as Schedule I overnight, Colin proactively removed all products before enforcement began and warned other operators who were unknowingly shipping Schedule I narcotics. We absorbed a major revenue loss to act ethically — that’s the kind of company Van Buren County residents can trust.

October 7, 2022 — Biden Marijuana Pardon: This feature revealed that Colin has personally faced marijuana possession charges. That personal history transforms our entire media record — every quote about therapy and education carries additional weight when you understand we’ve lived the consequences of cannabis criminalization. For the approximately 300,000 Iowans with cannabis convictions who face housing, loan, and banking challenges, we understand because we’ve been there.

April 21, 2023 — Texas Marijuana Laws: Our most recent feature captured Colin growing hemp on camera and describing the present as a “Renaissance” that should be enjoyed. The comparison between Texas (10,000 active medical cannabis patients) and Florida (700,000 patients with two-thirds the population) demonstrates untapped demand that applies to Iowa’s restrictive program too.

Current Operations — Licensed, Verified, and Ready to Serve Van Buren County

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). We’ve been operating since 2019, generate approximately one million dollars in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed. Our products are not mass-produced — they’re carefully crafted with a personal touch, from the artwork on the packaging to the formulations inside.

All artwork, formulations, and packaging are created in-house in Houston, using only our own recipes and ideas. We bring Houston grit, McAllen roots, and a builder’s mindset to our company, but our posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

We know Van Buren County values honesty, hard work, and straightforward talk. That’s exactly what we offer.

Our RSO Philosophy — Four Core Principles for Van Buren County

1. Accessibility Over Gatekeeping

No medical card is required. Anyone age 21 or older can purchase. We ship nationwide across the United States and internationally to customers who verify local legality.

Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally. For Van Buren County residents who don’t qualify for Iowa’s restrictive medical cannabis program — which only covers a handful of conditions like cancer, chronic pain, PTSD, and terminal illness with severe limitations — this means you can access our RSO without jumping through bureaucratic hoops.

Iowa’s medical cannabis program requires patients to register, pay fees, and purchase only from state-licensed dispensaries in urban areas like Davenport or Waterloo — hours away from Van Buren County. We ship directly to your door in Keosauqua, Birmingham, Milton, or anywhere in the county.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency.

Simpson believed patients should control their medicine; we engineered a product that puts that control in your hands through chemistry. For Van Buren County residents who operate tractors, work in the local grain elevators, drive trucks, or need to stay sharp for their jobs, this means you can use the raw form during the day with zero impairment, then activate it at night when you need stronger relief.

3. Open-Source Formulas

We publish our complete formulas publicly — every cannabinoid, every milligram amount, every percentage — so that anyone who cannot afford our products can source ingredients and make their own version.

Simpson gave his oil away for free and taught people how to make it. We adapted that ethos for the modern cannabinoid marketplace: selling a professionally manufactured product and publishing the recipe. For Van Buren County’s economically diverse community — where median household income is below the state average and agricultural income can be unpredictable — this means you’re not shut out if you can’t afford $129.99. The knowledge is free.

Here’s our complete sublingual formula, published for Van Buren County:

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5%
• Format: 30mL bottle
• Active cannabinoids per mL: 553mg

And our vape formula for Van Buren County DIYers:

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%
• Format: 1 Gram cartridge

4. Evidence-Informed, Not Evidence-Overstating

The GENERAL KNOWLEDGE section of this document represents our commitment to honest education about what science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish what is well-supported, what is emerging, and what is overstated.

For Van Buren County residents who value education and want to make informed decisions — whether you’re a farmer researching options for chronic pain, a caregiver looking into cannabis for a loved one with cancer, or a veteran exploring PTSD alternatives — we provide the actual research, not marketing hype.

Farm Bill Compliance and the THCa Legal Framework for Iowa

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight at the federal level. This legal framework is the foundation of our RSO product design.

Our RSO Sublingual Oil contains only 90mg of delta-9 THC in the entire 30mL bottle — 3mg per mL — well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law and in Iowa.

Iowa-specific context: Iowa’s hemp law (Iowa Code Chapter 204) aligns with the Farm Bill, permitting hemp-derived products with less than 0.3% delta-9 THC. However, Iowa’s medical cannabis program (Iowa Code Chapter 124E) remains separate and more restrictive. Our products are available under the hemp law, not the medical cannabis program, meaning no medical card is required for Van Buren County residents.

THCa is the acidic, non-psychoactive precursor to delta-9 THC. It’s not delta-9 THC itself, which is legally significant: THCa is Farm Bill compliant at point of sale because it hasn’t been converted to delta-9 THC.

The practical significance is substantial. You can legally purchase our product in Van Buren County, possess it under Iowa law, and choose whether to activate it at home. The product arrives raw (non-psychoactive) and can stay that way indefinitely.

Important legal notice: THCa converts to delta-9 THC when heated. Customers are responsible for understanding and complying with Iowa laws regarding cannabinoid products. We ship with full documentation, Certificates of Analysis, and receipts. International customers accept all customs and legal responsibility.

The Decarboxylation Choice — Patient-Controlled Potency for Van Buren County

Traditional RSO was always fully decarboxylated. You had no choice about psychoactivity — it was always psychoactive.

Our sublingual formula contains 1,500mg of THCa in its acidic, non-psychoactive form. This creates three distinct usage options:

Option 1 — Raw, no heat: All 1,500mg stays as THCa — completely non-psychoactive. The THCa evidence describes potential anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. This is compatible with operating farm equipment, driving the winding roads of Van Buren County, working at the grain elevator, or parenting with zero psychoactive impairment.

Option 2 — Fully activated, home decarboxylation: Heating oil at 260°F (125°C) for 45-60 minutes in an oven-safe glass container converts 1,500mg THCa to ~1,315mg delta-9 THC. Combined with the existing 90mg delta-9 THC, this yields ~1,405mg total delta-9 THC. Combined with 6,000mg delta-8 THC, the activated product achieves psychoactive potency comparable to traditional illegal RSO — 100% legally, because decarboxylation occurs at your discretion after purchase. You can also transfer a controlled portion to a second container, decarboxylating only what you intend to use while preserving the remainder raw.

Option 3 — Vape, auto-decarboxylation: Our vape cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids — the fastest-onset RSO delivery method available.

Conversion chemistry: THCa’s molecular weight is 358.47 g/mol. The ratio is ~1mg THCa = 0.877mg delta-9 THC after decarboxylation, reflecting CO₂ molecule loss.

This design puts the potency decision entirely in your hands — aligning with Rick Simpson’s principle that patients should control their medicine, but implementing it through actual product chemistry rather than just philosophy.

Solvent-Free Production — Why It Matters for Van Buren County

Traditional RSO used toxic solvents. Modern extraction uses food-grade ethanol or CO₂. Our approach goes further: we don’t extract at all. We formulate a blend of individual cannabinoid distillates and isolates in a controlled environment — no solvents in the finished product.

This eliminates the residual solvent risk that is one of the most significant safety concerns with traditional RSO production. For Van Buren County residents who may have tried DIY cannabis extraction (common in rural areas where dispensaries are far away), this is critical safety education. The fire risk alone from solvent-based extraction in rural settings — where emergency response may take 20-30 minutes — makes our solvent-free approach essential.

We use organic MCT oil as the carrier base — food-grade, facilitating absorption, with neutral taste. Third-party lab testing covers potency, terpenes, pesticides, heavy metals, residual solvents, and microbial contaminants. COAs are available on request.

Our Complete Product Portfolio — Beyond RSO for Van Buren County Needs

Asshole Peach — Our most popular product. Carefully formulated for euphoric, long-lasting sensation. Particularly favored by veterans for pain and PTSD relief. For Van Buren County’s veteran community — those who served and returned with invisible wounds — this product has been a game-changer.

Peace Gummies — Developed directly from Colin’s own experience with PTSD and benzodiazepine addiction. These helped him quit Xanax cold turkey. Also available in vape form for quick relief — Colin personally uses this to manage his insomnia and severe PTSD. For Van Buren County residents trapped in prescription cycles, this represents hope grounded in real experience.

Custom creations — We offer custom-made products tailored to specific needs. Whether it’s specific cannabinoid ratios, particular delivery formats, or formulations for unique health circumstances (vegans, diabetics, specific dietary needs), we design targeted products on request. For Van Buren County residents with unique health challenges that off-the-shelf products don’t address, this customization is invaluable.

Two Product Formats — Sublingual Oil and Vape Cartridge

We offer our RSO formula in two delivery formats, each designed for different use cases:

RSO Sublingual Oil — $129.99

• 30mL bottle (1 fl oz)
• 16,590mg total cannabinoids (553mg per mL)
• Seven cannabinoids: CBD 4,500mg, CBG 3,000mg, delta-8 THC 6,000mg, THCa 1,500mg, delta-9 THC 90mg, CBN 750mg, CBC 750mg
• Live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper for precise dosing in 0.1mL increments
• Onset: 15-45 minutes (sublingual absorption)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (partially bypasses first-pass liver metabolism)
• Approximately 40-60 doses per bottle depending on serving size

For Van Buren County usage: This is your daily workhorse. The graduated dropper lets you dose precisely whether you’re managing chronic pain from years of farm work, addressing PTSD from military service, or supporting sleep. The long duration means you don’t have to re-dose frequently during a busy day.

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900mg+ total cannabinoids
• Same six-cannabinoid ratio as sublingual (no separate delta-9 THC listing because THCa auto-decarbs at vaping temperature)
• Live terpenes at 5%+
• 510-thread universal battery compatibility (works with standard batteries available locally)
• Onset: 1-2 minutes (fastest cannabinoid delivery)
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35% (variable based on inhalation technique)
• Automatic THCa decarboxylation at vaping temperature (400-450°F)

For Van Buren County usage: This is your breakthrough relief. When pain spikes suddenly, when a panic attack hits, when chemo nausea comes on strong — you need relief in minutes, not hours. The vape delivers that speed.

When to Use Each Format in Van Buren County

Use case	Recommended format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset — crucial when you need immediate help
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration — covers you through work or night
Maximum bioavailability	Sublingual	13-19% absorption — most efficient use of product
Portability and discretion	Vape	Compact, no measuring — fits in your pocket for town trips
Precise dosing control	Sublingual	Graduated dropper in 0.1mL increments — perfect for titration
Daytime non-psychoactive use	Sublingual (raw, no heat)	THCa stays inactive—zero impairment for operating equipment
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC for full therapeutic strength

Competitive Comparison — How OilWell Stacks Up for Van Buren County

OilWell RSO vs. Iowa’s Medical Cannabis Program (TCUP)

Iowa’s medical cannabis program (TCUP) dispensaries sell products that are THC-only, require a medical card with qualifying conditions, and force patients to travel to urban dispensaries. For Van Buren County residents, that means driving 2-3 hours round-trip to Davenport or Waterloo, paying for a medical card, and being limited to expensive, single-cannabinoid products.

Dimension	Iowa TCUP Dispensary RSO	OilWell RSO
Cannabinoid profile	THC-only (~420mg per 0.5g syringe)	7 cannabinoids: CBD, CBG, delta-8, THCa, delta-9, CBN, CBC
CBG content	0mg	3,000mg
CBN content	0mg	750mg
CBC content	0mg	750mg
Patient-controlled potency	No — always psychoactive	Yes — THCa non-psychoactive until you heat it
Access requirements	TCUP card + qualifying condition	Age 21+ only — no medical card needed
Qualifying conditions	Cancer, PTSD, epilepsy, terminal illness, etc.	None required
Delivery	Must travel to urban dispensary (2-3 hour round trip)	Ships directly to your Van Buren County address
Farm Bill compliant	No — state medical program	Yes — less than 0.3% delta-9 THC

OilWell RSO vs. Hemp CBD Products (Lazarus Naturals, etc.)

Many Van Buren County residents have tried hemp CBD products from local stores or online. While these have their place, they offer a fraction of the cannabinoid content and no psychoactive option.

Dimension	Typical Hemp CBD RSO (10mL, 1,000mg)	OilWell RSO (30mL, 16,590mg)
Total cannabinoids	1,000mg	16,590mg
CBD content	~950mg	4,500mg
CBG content	15.5mg	3,000mg
Delta-8 THC	0mg	6,000mg
THCa (convertible)	Minimal	1,500mg (converts to ~1,315mg delta-9 THC)
Psychoactive option	No meaningful effect	Yes — via THCa decarboxylation
Approximate price	$40-50	$129.99

Bottom line for Van Buren County: You’re getting 16x the total cannabinoids, a complete multi-cannabinoid profile, the ability to control psychoactivity, and direct delivery — all for about 2.5x the price of a basic CBD product. The value is clear.

Condition-Specific Usage Context for Van Buren County Residents

Important disclaimer: The following contexts are informed by cannabinoid research cited in our GENERAL KNOWLEDGE section and our formulation rationale. They are not medical prescriptions, not FDA-approved treatment protocols, and not substitutes for professional medical care. Always consult a qualified healthcare provider, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-Related Nausea and Appetite Support

Van Buren County residents undergoing chemo at Southeast Iowa Regional Medical Center in Keosauqua or traveling to Iowa City for treatment often face severe nausea and appetite loss.

• Pre-chemo: 0.5-1.0mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief (1-2 minute onset)
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0-2.0mL sublingual before bed (delivers 25-50mg CBN)

Evidence context: Delta-8 THC antiemetic evidence [9], delta-9 THC nausea and vomiting evidence [1][13], CBD anxiolytic buffering [3]

Chronic Pain (Farm Injuries, Arthritis, Neuropathy)

Van Buren County’s agricultural heritage means generations of physical labor leading to chronic pain conditions.

• Daytime: 0.3-0.5mL raw sublingual — anti-inflammatory cannabinoid exposure without psychoactive impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual — combines pain relief with CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset

Evidence context: CBD pain evidence [4], delta-9 THC pain evidence [13], beta-caryophyllene CB2 agonism [24], THCa COX-2 inhibition [12]

Sleep Support

Sleep disorders are common in rural areas — whether from pain, anxiety, or the stress of agricultural economic uncertainty.

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: Delivers 50mg CBN — the dosage level investigated in 2024 sleep literature
• At 1.0mL: Delivers 25mg CBN — above the 20mg threshold associated with reduced sleep disturbance

Evidence context: CBN sleep evidence [16][17], cannabis and sleep review literature

Anxiety and Stress

From economic pressures to isolation, rural life creates unique stressors.

• Daytime functional relief: 0.3mL raw sublingual — CBD and CBG address anxiety without impairment
• Nighttime: 1.0mL sublingual — full profile including CBN for sleep architecture

Evidence context: CBD anxiety evidence [3], CBG pharmacology [7][8], limonene entourage-effect evidence [20]

General Titration Principle — Start Low, Go Slow

Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications (especially important for Van Buren County residents taking multiple prescriptions), and other factors.

Delivery and Global Accessibility — How Van Buren County Gets Our Products

We operate the only same-day RSO delivery system in Houston. But for Van Buren County, we offer something even more important: reliable, legal shipping directly to your rural Iowa address.

Nationwide Shipping to Iowa

• All 50 states where Farm Bill-compliant products are legal (including Iowa)
• USPS Priority Mail (2-3 business days) — reliable delivery to rural routes
• FedEx and UPS Ground (3-5 business days)
• Discreet packaging with no cannabis branding visible — respects your privacy in a small community
• Tracking provided for all orders — you know exactly when it arrives
• Temperature-stable packaging for Iowa’s extreme summer heat and winter cold
• Signature-required option available — ensures secure delivery

International Shipping

Yes, we ship globally. The THCa legal framework makes this possible: because the product contains less than 0.3% delta-9 THC at point of sale, it meets the definition of a hemp-derived product under the 2018 Farm Bill and is shippable to jurisdictions with compatible hemp laws.

• Full documentation included: COAs, receipts for customs
• Minimum flat-fee shipping applies; excessive costs billed to customer
• Customer responsibility: You verify legality in your jurisdiction and accept all customs/legal risk
• Contact: (832) 416-2816 or [email protected]

The significance for Van Buren County: Rick Simpson could not ship his oil anywhere — it was Schedule I, illegal to produce, possess, or transport. A cancer patient in Van Buren County can now potentially access the same clinical-strength multi-cannabinoid RSO formula that a Houston resident receives via same-day delivery. We’ve built a product that can move across borders legally — completing a piece of Simpson’s vision that prohibition made impossible.

How Our Formulas Connect to The Evidence for Van Buren County

Every cannabinoid in our formula — CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC — has its own evidence profile in our GENERAL KNOWLEDGE section. Every terpene — limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene — is covered with preclinical and review-level evidence.

When we make specific research claims about individual cannabinoids or terpenes, this document provides the source evaluation context — the same peer-reviewed citations, the same evidence-tier assessments, the same cautious interpretation framework.

Our GENERAL KNOWLEDGE section’s evidence hierarchy, overstatement warnings, and safety notes apply equally to our own products. We don’t exempt ourselves from the standards we apply to the broader field. That is intentional.

Our position — as stated by Colin Valencia in 2019 — is that people deserve the best possible version of the information so they can give it a fair shot and decide for themselves whether it’s right or wrong for them. This document is the research foundation for that position.

GENERAL KNOWLEDGE — The Science Behind The Formulas for Van Buren County

Research Method and Evidence Weighting

This section prioritizes sources in the following order: human clinical evidence, systematic reviews and meta-analyses, NIH and institutional summaries, then mechanistic or preclinical literature when human data are sparse. That weighting matters because the evidence base is not evenly distributed. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes are still more dependent on reviews, animal work, and in vitro pharmacology [1]-[29].

Institutional Baseline from NIH and Related Sources

• NCCIH: Strongest established evidence is for certain rare epilepsies, chemotherapy-related nausea and vomiting, and appetite or weight-loss indications associated with HIV/AIDS. Only modest evidence for chronic pain and multiple-sclerosis-related symptoms [1].
• FDA: Has not approved the cannabis plant itself for medical use, although purified CBD (Epidiolex) and synthetic THC-like drugs (dronabinol, nabilone) have specific approvals [1].
• Safety concerns: Impairment, motor vehicle crash risk, cannabis use disorder, pregnancy-related concerns, accidental pediatric exposure, contamination or labeling inaccuracy, and THC-vape lung-injury concerns [1].

Cannabinoid Profiles

CBD: Strongest human evidence in our formula set, especially as purified product. Best support in seizure disorders (Epidiolex) [1][2]. Anxiety research shows statistically significant anxiolytic signal but limited clinical samples [3]. Pain research is promising but heterogeneous [4]. Sleep research remains methodologically weak [5]. Safety concerns include liver enzyme elevation and drug interactions [6].

CBG: Mostly review-level and preclinical; human evidence sparse [7][8]. Pharmacologically interesting (CB receptors, alpha-2 adrenoceptors, 5-HT1A) but not yet clinically established. Commercially sold despite thin evidence base [7].

Delta-8 THC: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 [9]-[11]. Similar pharmacokinetic behavior but less potent due to weaker CB1 affinity [9]. Public health literature dominated by animal studies, product chemistry, and use reports [10]. Manufacturing concerns about byproducts and testing [11].

THCa: Important chemically but low on direct human therapeutic evidence [12]. Does not produce psychoactive effects associated with THC if it stays acidic. Research status: in vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, antineoplastic possibilities, but not established human outcomes [12].

Delta-9 THC: Strongest human evidence of psychoactive cannabinoids listed, but also clearest adverse-effect burden [1][13]-[15]. Institutionally supported for chemo nausea, HIV/AIDS appetite, some MS/pain outcomes [1]. Pain review shows short-term benefit but increased dizziness, sedation, nausea [13]. Classic pharmacokinetics: inhaled onset seconds-minutes, oral onset later, longer duration [14]. Mental health risks include psychosis/schizophrenia associations and cannabis use disorder [15]. Safety concerns: anxiety/panic at high doses, tachycardia, blood pressure changes, dependency, pregnancy concerns [1][14][15].

CBN: Weak human evidence; marketing ahead of data [12][16][17]. Reputation for sleep/sedation widespread but clinical support thin [16][17]. 2021 narrative review found no clinical trials using validated sleep questionnaires or polysomnography [16]. 2024 sleep review concluded research doesn’t match real-world use scale [17].

CBC: Emerging, intriguing, overwhelmingly preclinical [18][19]. 2024 review argues distinct pharmacodynamics and therapeutic potential (antinociceptive, antibacterial, anti-seizure) but notes over-the-counter products sold with little evidence [18]. Preclinical work shows anti-inflammatory, reduced gut hypermobility, modest rodent analgesia [19].

Terpene Profiles

Terpene claims need stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models rather than controlled human cannabis studies. Entourage hypotheses are influential but robust clinical proof remains limited [20][29].

Limonene: Review and preclinical evidence [20]-[22]. 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory activities, but mostly from nonhuman/non-cannabis literature [21]. Safety note: oxidation products are contact allergens [22].

Myrcene: Mostly preclinical, limited human evidence [20][23]. 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties but states human studies lacking [23]. Sedation claims stronger than evidence supports [20][23].

Caryophyllene: Among most mechanistically interesting because selective CB2 receptor agonist [24]. 2021 review describes anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions [24]. Strongest candidate for cannabinoid-system significance, but still not clinically proven [24].

Pinene: Promising preclinical, weak human confirmation [20][25]. 2021 review found antioxidant, anti-inflammatory, neuroprotective signals justifying future study but emphasized lack of clinical trials [25]. Memory/attention claims remain hypotheses [20][25].

Linalool: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26]. 2021 brain-health review found enough preclinical signal to justify investigation but emphasized lack of robust human trials [25]. Separate literature discusses antidepressant mechanisms but remains translational [26]. Oxidized linalool hydroperoxides are allergens [22].

Humulene: Translationally interesting but early [20][27]. 2024 scoping review of 340 articles found broad preclinical evidence for anti-inflammatory effects, some rodent work suggesting cannabimimetic properties [27]. Valuable for hypothesis generation but not established human efficacy [27].

Terpinolene: Least clinically characterized [20][28]. 2021 systematic review of 2,449 records found range of reported biological effects but evidence base dominated by in silico, in vitro, animal studies [28]. Remains especially underdeveloped clinically [20][28].

Research Limits and Interpretation — What Van Buren County Needs to Know

1. Evidence base is highly uneven. CBD and delta-9 THC support most detailed statements; others require more caution [1]-[29].

2. Extract/molecule/synthetic/terpene data aren’t interchangeable. Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. One common error is letting evidence from one category stand in for another.

3. Minor cannabinoids are commercially interesting BECAUSE they’re underexplored. That also means claims around them often become inflated.

4. Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect interpretation in real-world products [1][10][11][14].

5. THCa chemistry changes with storage/heating. Storage and heating can change actual exposure profile by converting acidic cannabinoids into neutral cannabinoids like THC [12].

Common Overstatements to Avoid — Straight Talk for Van Buren County

• Overstatement: CBN is a clinically proven sleep cannabinoid.
  More accurate: specific sleep evidence for CBN remains weak and dated, with no strong validated-trial base yet identified [16][17].

• Overstatement: Myrcene is a proven human sedative that reliably explains couch-lock.
  More accurate: myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

• Overstatement: Terpenes in general have proven entourage effects in patients.
  More accurate: entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa into THC, changing effective exposure [12].

• Overstatement: Delta-8 THC is safe because it’s hemp-derived.
  More accurate: delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical Takeaways for Van Buren County

1. CBD and delta-9 THC are the most evidence-developed actives in these formulas.
2. Delta-8 THC is not a trivial or purely mild ingredient; it’s a psychoactive cannabinoid with less robust safety and efficacy characterization than delta-9 THC.
3. THCa meaningfully changes with processing and should not be interpreted the same way in raw, gently handled, and heated formats.
4. CBG, CBN, and CBC are scientifically credible but clinically immature compared with CBD and THC.
5. Terpene claims should be careful. They likely contribute to aroma, flavor, and potentially some biologic activity, but compound-specific human therapeutic claims should be made only where directly supported.

Our Promise to Van Buren County

OilWell Cannabis is more than a brand — it’s a promise to our customers that we will always strive to deliver the best, most thoughtful cannabis products available. We’re not here to follow trends. We’re here to set them. And as we continue to grow, our focus remains on maintaining the same level of integrity, creativity, and commitment that has defined us from the day Bentley got up, walked across the room, and brought his ball to play.

For Van Buren County residents considering RSO — whether you’re a cancer patient at the Van Buren County Hospital, a veteran in Birmingham dealing with PTSD, a farmer in Milton with chronic pain, or a caregiver in Keosauqua looking for options — we offer something unique: clinical-strength, multi-cannabinoid RSO formulas backed by actual research, published openly for transparency, delivered legally to your door, and designed to give you control over your own medicine.

We can’t promise cures. No ethical company can. But we can promise honesty, quality, and the best possible version of the information so you can give it a fair shot and decide for yourself whether it’s right or wrong for you.

That’s the OilWell difference. That’s what we bring to Van Buren County.

References

Simpson R. Phoenix Tears: The Rick Simpson Story. Simpson RamaDur LLC; 2012.

Laurette C, director. Run From The Cure: The Rick Simpson Story . 2005. Distributed via phoenixtears.ca and online platforms.

Simpson R. Instructions and dosing information published on phoenixtears.ca. Multiple dates. Accessed March 2026.

Velasco G, Sánchez C, Guzmán M. Towards the use of cannabinoids as antitumour agents. Nat Rev Cancer. 2012;12(6):436-444. PMID: 22555283.

Guzmán M, Duarte MJ, Blázquez C, et al. A pilot clinical study of delta-9-tetrahydrocannabinol in patients with recurrent glioblastoma multiforme. Br J Cancer. 2006;95(2):197-203. PMID: 16804518.

National Cancer Institute. Cannabis and Cannabinoids (PDQ) — Health Professional Version. NIH/NCI. Updated 2024. Available at: https://www.cancer.gov/about-cancer/treatment/cam/hp/cannabis-pdq

[1] National Center for Complementary and Integrative Health. Cannabis Marijuana and Cannabinoids: What You Need To Know. NIH/NCCIH. Accessed March 2026. Available at: https://www.nccih.nih.gov/health/cannabis-marijuana-and-cannabinoids-what-you-need-to-know

[2] Talwar A, Estes E, Aparasu R, Reddy DS. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis. Exp Neurol. 2023;359:114238. PMID: 36206805.

[3] Han K, Wang JY, Wang PY, Peng YC. Therapeutic potential of cannabidiol CBD in anxiety disorders: A systematic review and meta-analysis. Psychiatry Res. 2024;339:116049. PMID: 38924898.

[4] Cásedas G, Yarza-Sancho M, López V. Cannabidiol CBD: A systematic review of clinical and preclinical evidence in the treatment of pain. Pharmaceuticals Basel. 2024;17(11):1438. PMID: 39598350.

[5] Ranum RM, Whipple MO, Croghan I, Bauer B, Toussaint LL, Vincent A. Use of cannabidiol in the management of insomnia: A systematic review. Cannabis Cannabinoid Res. 2023;8(2):213-229. PMID: 36149724.

[6] Lo LA, Christiansen A, Eadie L, Strickland JC, Kim DD, Boivin M, Barr AM, MacCallum CA. Cannabidiol-associated hepatotoxicity: A systematic review and meta-analysis. J Intern Med. 2023;293(6):724-752. PMID: 36912195.

[7] Nachnani R, Raup-Konsavage WM, Vrana KE. The pharmacological case for cannabigerol. J Pharmacol Exp Ther. 2021;376(2):204-212. PMID: 33168643.

[8] Li S, Li W, Malhi NK, Huang J, Li Q, Zhou Z, Wang R, Peng J, Yin T, Wang H. Cannabigerol CBG: A comprehensive review of its molecular mechanisms and therapeutic potential. Molecules. 2024;29(22):5471. PMID: 39598860.

[9] Tagen M, Klumpers LE. Review of delta-8-tetrahydrocannabinol delta8 THC: Comparative pharmacology with delta9 THC. Br J Pharmacol. 2022;179(15):3915-3933. PMID: 35523678.

[10] LoParco CR, Rossheim ME, Walters ST, Zhou Z, Olsson S, Sussman SY. Delta-8 tetrahydrocannabinol: A scoping review and commentary. Addiction. 2023;118(6):1011-1028. PMID: 36710464.

[11] Abdel-Kader MS, Radwan MM, Metwaly AM, Eissa IH, Hazekamp A, ElSohly MA. Chemistry and pharmacology of Delta-8-Tetrahydrocannabinol. Molecules. 2024;29(6):1249. PMID: 38542886.

[12] Moreno-Sanz G. Can You Pass the Acid Test? Critical review and novel therapeutic perspectives of delta9-Tetrahydrocannabinolic Acid A. Cannabis Cannabinoid Res. 2016;1(1):124-130. PMID: 28861488.

[13] McDonagh MS, Morasco BJ, Wagner J, Ahmed AY, Fu R, Kansagara D, Chou R. Cannabis-based products for chronic pain: A systematic review. Ann Intern Med. 2022;175(8):1143-1153. PMID: 35667066.

[14] Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet. 2003;42(4):327-360. PMID: 12648025.

[15] Rittiphairoj T, Leslie L, Oberste JP, Yim TW, Tung G, Bero L, Riggs P, Hutchison K, Samet J, Li T. High-concentration delta-9-tetrahydrocannabinol cannabis products and mental health outcomes: A systematic review. Ann Intern Med. 2025;178(10):1429-1440. PMID: 40854216.

[16] Corroon J. Cannabinol and sleep: Separating fact from fiction. Cannabis Cannabinoid Res. 2021;6(5):366-371. PMID: 34468204.

[17] Lavender I, Garden G, Grunstein RR, Yee BJ, Hoyos CM. Using cannabis and CBD to sleep: An updated review. Curr Psychiatry Rep. 2024;26(12):712-727. PMID: 39612156.

[18] Sepulveda DE, Vrana KE, Kellogg JJ, Bisanz JE, Desai D, Graziane NM, Raup-Konsavage WM. The potential of cannabichromene as a therapeutic agent. J Pharmacol Exp Ther. 2024;391(2):206-213. PMID: 38777605.

[19] Zagožen M, Čerenak A, Kreft S. Cannabigerol and cannabichromene in Cannabis sativa L. Acta Pharm. 2021;71(3):355-364. PMID: 36654096.

[20] André R, Gomes AP, Pereira-Leite C, Marques-da-Costa A, Monteiro Rodrigues L, Sassano M, Rijo P, Costa MDC. The entourage effect in cannabis medicinal products: A comprehensive review. Pharmaceuticals Basel. 2024;17(11):1543. PMID: 39598452.

[21] Anandakumar P, Kamaraj S, Vanitha MK. D-limonene: A multifunctional compound with potent therapeutic effects. J Food Biochem. 2021;45(1):e13566. PMID: 33289132.

[22] Ogueta IA, Brared Christensson J, Giménez-Arnau E, Brans R, Wilkinson M, Stingeni L, Foti C, Aerts O, Svedman C, Gonçalo M, Giménez-Arnau A. Limonene and linalool hydroperoxides review: Pros and cons for routine patch testing. Contact Dermatitis. 2022;87(1):1-12. PMID: 35122274.

[23] Surendran S, Qassadi F, Surendran G, Lilley D, Heinrich M. Myrcene: What are the potential health benefits of this flavouring and aroma agent? Front Nutr. 2021;8:699666. PMID: 34350208.

[24] Hashiesh HM, Sharma C, Goyal SN, Sadek B, Jha NK, Al Kaabi J, Ojha S. A focused review on CB2 receptor-selective pharmacological properties and therapeutic potential of beta-caryophyllene, a dietary cannabinoid. Biomed Pharmacother. 2021;140:111639. PMID: 34091179.

[25] Weston-Green K, Clunas H, Jimenez Naranjo C. A review of the potential use of pinene and linalool as terpene-based medicines for brain health: Discovering novel therapeutics in the flavours and fragrances of cannabis. Front Psychiatry. 2021;12:583211. PMID: 34512404.

[26] Dos Santos ÉRQ, Maia JGS, Fontes-Júnior EA, do Socorro Ferraz Maia C. Linalool as a therapeutic and medicinal tool in depression treatment: A review. Curr Neuropharmacol. 2022;20(6):1073-1092. PMID: 34544345.

[27] Dalavaye N, Nicholas M, Pillai M, Erridge S, Sodergren MH. The clinical translation of alpha-humulene: A scoping review. Planta Med. 2024;90(9):664-674. PMID: 38626911.

[28] Menezes IO, Scherf JR, Martins AOBPB, Ramos AGB, Quintans JSS, Coutinho HDM, Ribeiro-Filho J, de Menezes IRA. Biological properties of terpinolene evidenced by in silico, in vitro and in vivo studies: A systematic review. Phytomedicine. 2021;93:153768. PMID: 34634744.

[29] Russo EB. Taming THC: Potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. Br J Pharmacol. 2011;163(7):1344-1364. PMID: 21749363.

Final Thoughts for Van Buren County

We’ve come a long way from Rick Simpson’s kitchen in Nova Scotia to a Houston laboratory serving customers in Van Buren County, Iowa. We’ve evolved from crude, solvent-based extractions to precision-formulated, lab-tested, multi-cannabinoid medicines. We’ve moved from underground distribution to legal, regulated commerce that ships directly to your door.

But some things haven’t changed: the desperation that drives people to seek alternatives when conventional medicine fails, the hope that something natural might help where pharmaceuticals have harmed, the fundamental belief that patients should control their own medicine.

In Van Buren County — where the cornfields stretch to the horizon, where neighbors still help neighbors, where trust is earned not given — we offer something rare: transparency, quality, and honesty. We publish our formulas. We cite our research. We tell you what we know and what we don’t. We ship legally to your door. And we put the power of choice in your hands.

Whether you’re fighting cancer, managing chronic pain, battling PTSD, helping a loved one through chemo, or simply exploring options for better sleep — we see you. We respect your intelligence. And we’re here to provide the best possible version of the information and products so you can give them a fair shot.

That’s the OilWell promise. That’s what we bring to Van Buren County.

Order today: https://oilwellcbd.com/thca-rick-simpson-oil-rso-by-oilwell-cannabis-of-houston-texas/
Contact us: (832) 416-2816 or [email protected]
Address: 810 Richmond Ave, Houston, TX 77006

This product has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease. Must be 21+ to purchase. Keep out of reach of children. Consult your physician before use, especially if you are pregnant, nursing, have a medical condition, or take medications. Do not operate vehicles or machinery while using this product. Buyer assumes all responsibility for compliance with local laws.